KAI Pharmaceuticals Enterprise Account Executive Salaries in Santa Barbara, CA
The average KAI Pharmaceuticals Enterprise Account Executive in Santa Barbara, CA earns an estimated $114,538 annually, which includes an estimated base salary of $87,496 with a $27,043 bonus. KAI Pharmaceuticals' Enterprise Account Executive compensation is $1,064 more than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at KAI Pharmaceuticals in Santa Barbara, CA can range from $52,000 - $205,000.
In Santa Barbara, CA, The Business Development Department at KAI Pharmaceuticals earns $1,119 more on average than the Engineering Department.
Last updated 5 years ago.
- $87,496
- avg. base
- $27,043
- avg. bonus
Enterprise Account Executive Salaries at KAI Pharmaceuticals
In Santa Barbara, CA, Enterprise Account Executives earn $1,818 more than Account Managers, and $39,439 less than Business Development Managers.
Compensation at KAI Pharmaceuticals by Department
In Santa Barbara, CA, The Business Development Department averages $1,119 more than the Engineering Department, and $13,927 less than the Legal Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to KAI Pharmaceuticals reported making $115,417, while the average male Enterprise Account Executive at similar sized companies reported making $130,365.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average African American/Black Enterprise Account Executive at companies similar size to KAI Pharmaceuticals reported making $130,663, while the average Hispanic or Latino Enterprise Account Executive at similar sized companies reported making $107,000.
How Enterprise Account Executives at KAI Pharmaceuticals Rate Their Compensation
The majority of Enterprise Account Executives at KAI Pharmaceuticals believe they're compensated fairly. 100% of Enterprise Account Executives at KAI Pharmaceuticals say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at KAI Pharmaceuticals
